Aitia

📍 Cambridge, United States🗓 Founded 2000👥 88 employees💰 Last funded Nov 2019
Biotechnology Research
LinkedIn
Aitia is the leader in leveraging the convergence of patient multiomic and outcome data, high-performance computing, and causal learning and AI to reveal the deeply complex circuitry of human biology to identify novel targets driving disease and focused patient recruitment for clinical development. With this new knowledge, which we capture in our Gemini Digital Twins (computational representatives) of human disease, we work with pharmaceutical partners to apply our discoveries to the next generation of breakthrough therapies.
4
Total investors
1
Early stage
0
Mid stage
0
Late stage
2000
Founded

Investors

4 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
4
Investor activity2001–2019 · investors recorded per year
20011201412017120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Aitia?
Aitia has 4 investors on record on gritt.io, including 1 early-stage backers.
When did Aitia last raise funding?
The most recent investment in Aitia recorded on gritt.io was in November 2019.
When was Aitia founded?
Aitia was founded in 2000.
What industry is Aitia in?
Aitia operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Aitia based?
Aitia is headquartered in Cambridge, United States.